Study of Vanadium Supplement in Patients With Impaired Glucose Tolerance
Launched by UNIDAD DE INVESTIGACION MEDICA EN EPIDEMIOLOGIA CLINICA · Nov 19, 2007
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of impaired glucose tolerance
- • Body mass index from 25 to 35 kg/m2
- • History of type 2 diabetes mellitus in the first branch
- Exclusion Criteria:
- • Taking medication with known effects on carbohydrate or insulin metabolism
- • Thyroid diseases
- • Hepatic diseases
About Unidad De Investigacion Medica En Epidemiologia Clinica
The Unidad de Investigación Médica en Epidemiología Clínica is a leading clinical research organization dedicated to advancing public health through rigorous epidemiological studies and clinical trials. With a focus on understanding disease patterns and improving healthcare outcomes, the unit employs a multidisciplinary approach, integrating expertise in epidemiology, biostatistics, and clinical practice. Committed to ethical standards and scientific integrity, the organization collaborates with healthcare professionals, academic institutions, and industry partners to conduct innovative research that informs evidence-based practices and policy development in the field of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guadalajara, Jalisco, Mexico
Patients applied
Trial Officials
Omar Jacques-Camarena, MD, MSc
Principal Investigator
Unidad de Investigacion Medica en Epidemiologia Clinica
Manuel González-Ortiz, MD, MSc, PhD
Principal Investigator
Unidad de Investigacion Medica en Epidemiologia Clinica
Esperanza Martínez-Abundis, MD, MSc, PhD
Study Director
Unidad de Investigacion Medica en Epidemiologia Clinica
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials